指南与共识心血管CTMRUSPET

肥厚型心肌病患者多模态心血管影像检查建议:美国超声心动图学会更新版,与美国核心脏病学会、心血管磁共振学会及心血管计算机断层扫描学会合作制定

Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy: An Update from the American Society of Echocardiography, in Collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Cardiovascular Computed Tomography.
指南 / 共识 · J Am Soc Echocardiogr · 2022-01-01

该更新版建议由美国超声心动图学会联合美国核心脏病学会、心血管磁共振学会及心血管计算机断层扫描学会制定,围绕肥厚型心肌病的定义、病理生理机制及多模态影像在诊断、症状机制评估、治疗指导(室间隔减容治疗与二尖瓣修复)和心脏性猝死风险分层中的应用给出推荐。

要点

  • 静息与负荷影像可提供互补信息,帮助明确肥厚型心肌病患者症状的病理生理机制。
  • 先进影像技术用于指导室间隔减容治疗和二尖瓣修复等治疗决策。
  • 结合临床与影像参数的风险分层算法有助于筛选最可能从植入式心律转复除颤器获益的患者。

核心结论

  • 多模态影像的合理理解与应用是肥厚型心肌病准确诊断和长期管理的根本,静息与负荷影像提供互补信息以明确症状机制并指导治疗。

研究设计与样本

  • 美国超声心动图学会联合美国核心脏病学会、心血管磁共振学会及心血管计算机断层扫描学会制定的建议更新文件。

临床应用与阅片要点

  • 静息与负荷影像联合应用,以明确左心室流出道梗阻(伴或不伴显著二尖瓣反流)、舒张功能障碍、自主神经功能障碍、缺血及心律失常等肥厚型心肌病症状相关机制。
  • 先进影像用于指导室间隔减容治疗和二尖瓣修复等治疗选择。
  • 结合临床与影像参数的增强算法用于心脏性猝死风险分层,筛选最可能从植入式心律转复除颤器获益的患者。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Hypertrophic cardiomyopathy (HCM) is defined by the presence of left ventricular hypertrophy in the absence of other potentially causative cardiac, systemic, syndromic, or metabolic diseases. Symptoms can be related to a range of pathophysiologic mechanisms including left ventricular outflow tract obstruction with or without significant mitral regurgitation, diastolic dysfunction with heart failure with preserved and heart failure with reduced ejection fraction, autonomic dysfunction, ischemia, and arrhythmias. Appropriate understanding and utilization of multimodality imaging is fundamental to accurate diagnosis as well as longitudinal care of patients with HCM. Resting and stress imaging provide comprehensive and complementary information to help clarify mechanism(s) responsible for symptoms such that appropriate and timely treatment strategies may be implemented. Advanced imaging is relied upon to guide certain treatment options including septal reduction therapy and mitral valve repair. Using both clinical and imaging parameters, enhanced algorithms for sudden cardiac death risk stratification facilitate selection of HCM patients most likely to benefit from implantable cardioverter-defibrillators.

来源:J Am Soc Echocardiogr,查看原文。版权归原作者所有。

引用

  1. Nagueh SF, Phelan D, Abraham T, et al. Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy: An Update from the American Society of Echocardiography, in Collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2022. PMID: 35659037. doi:10.1016/j.echo.2022.03.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。